跳至主要内容
临床试验/EUCTR2020-000758-81-SE
EUCTR2020-000758-81-SE进行中(未招募)1 期

Chlorhexidine gluconate as treatment and prophylaxis of vulvovaginal Candidiasis - Chlorhex-KKDS-2021

Karolinska Institutet0 个研究点目标入组 60 人开始时间: 2020年10月29日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • 18-50 years of age
  • A history of > 2 candida infections the last year
  • Symptoms of acute vulvovaginal candida infection
  • Culture verified infection with Candida albicans
  • Adequate contraceptive method
  • Able to understand oral and written information in Swedish
  • The subject has given written consent to participate in the study
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 60
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range 0

排除标准

  • Severe somatic or mental illness (including liver and kidney failure and cardiac disease)
  • Immunosuppressive medication
  • Other ongoing gynecological infections
  • Allergy to fluconazole or chlorhexidine gluconate
  • Citalopram or other medication that might have impact on the QT interval (terfenadin, cisaprid, astemizol, pimozid, kinidin, erythromycin, halofantrin, amiodaron)
  • Participation or recent participation (30 days) in a clinical study with an investigational product. Previous participation in this study.

研究者

相似试验